Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Growth Arrest-Specific 6 in Chromophobe Renal Cell Carcinoma. | Oncology | 2022 | 35760058 | PubTator, text mining | PubMed |
| Serum Neutralizing and Enhancing Effects on African Swine Fever Virus Infectivity in Adherent Pig PBMC. | Viruses | 2022 | 35746720 | PubTator, text mining | PubMed |
| Nucleic Acid Vaccine Platform for DENGUE and ZIKA Flaviviruses. | Vaccines (Basel) | 2022 | 35746442 | PubTator, text mining | PubMed |
| Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma. | Int J Mol Sci | 2022 | 35743016 | PubTator, text mining | PubMed |
| Lung Inflammation Is Associated with Preeclampsia Development in the Rat. | Cells | 2022 | 35741013 | PubTator, text mining | PubMed |
| Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells. | Biomolecules | 2022 | 35740975 | PubTator, text mining | PubMed |
| Human pluripotent stem cells for the modelling of retinal pigment epithelium homeostasis and disease: A review. | Clin Exp Ophthalmol | 2022 | 35739648 | PubTator, text mining | PubMed |
| Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis. | J Immunother Cancer | 2022 | 35738798 | PubTator, text mining | PubMed |
| Pathogenesis and Manifestations of Zika Virus-Associated Ocular Diseases. | Trop Med Infect Dis | 2022 | 35736984 | PubTator, text mining | PubMed |
| Tuberculosis and Autoimmunity. | Pathophysiology | 2022 | 35736650 | PubTator, text mining | PubMed |
| Heterogeneity of Genetic Landscapes in Salivary Gland Tumors and Their Critical Roles in Current Management. | Medeni Med J | 2022 | 35735183 | PubTator, text mining | PubMed |
| N-glycosylation stabilizes MerTK and promotes hepatocellular carcinoma tumor growth. | Redox Biol | 2022 | 35728303 | PubTator, text mining | PubMed |
| Selective modulation of cell surface proteins during vaccinia infection: A resource for identifying viral immune evasion strategies. | PLoS Pathog | 2022 | 35727847 | PubTator, text mining | PubMed |
| Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy. | Cancer Manag Res | 2022 | 35720644 | PubTator, text mining | PubMed |
| MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancer. | J Clin Invest | 2022 | 35708914 | PubTator, text mining | PubMed |
| Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study. | BMC Cancer | 2022 | 35698081 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer. | Clin Cancer Res | 2022 | 35679021 | PubTator, text mining | PubMed |
| An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives. | Ther Clin Risk Manag | 2022 | 35677148 | PubTator, text mining | PubMed |
| Stromal changes in the aged lung induce an emergence from melanoma dormancy. | Nature | 2022 | 35650435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=34